After shoring up quality control at its Reykjavik manufacturing facility, the biotech has resubmitted a BLA to the FDA seeking an interchangeability designation for its Humira biosimilar.
FDA rejects Teva s high-potency biosimilar of Humira again pharmaphorum.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaphorum.com Daily Mail and Mail on Sunday newspapers.